Trials / Sponsors / Salarius Pharmaceuticals, LLC
Salarius Pharmaceuticals, LLC
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin's, Adult | EARLY_Phase 1 | 2024-03-15 |
| Unknown | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor | Phase 1 / Phase 2 | 2022-01-15 |
| Completed | Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-06-25 |
| Unknown | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcom Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue | Phase 1 | 2018-06-04 |